RU2012144143A - METHOD FOR DETERMINING THE SENSITIVITY OF A MALIGNANT TUMOR TO A CHEMICAL DRUG - Google Patents

METHOD FOR DETERMINING THE SENSITIVITY OF A MALIGNANT TUMOR TO A CHEMICAL DRUG Download PDF

Info

Publication number
RU2012144143A
RU2012144143A RU2012144143/14A RU2012144143A RU2012144143A RU 2012144143 A RU2012144143 A RU 2012144143A RU 2012144143/14 A RU2012144143/14 A RU 2012144143/14A RU 2012144143 A RU2012144143 A RU 2012144143A RU 2012144143 A RU2012144143 A RU 2012144143A
Authority
RU
Russia
Prior art keywords
sensitivity
determining
malignant tumor
drug
chemical drug
Prior art date
Application number
RU2012144143/14A
Other languages
Russian (ru)
Other versions
RU2534410C2 (en
Inventor
Муталим Рамазанович Рамазанов
Магомедзагир Исагаджиевич Нестеров
Загидат Муталимовна Рамазанова
Original Assignee
Государственное бюджетное образовательное учреждение высшего профессионального образования "Дагестанская государственная медицинская академия министерства здравоохранения и социального развития"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное бюджетное образовательное учреждение высшего профессионального образования "Дагестанская государственная медицинская академия министерства здравоохранения и социального развития" filed Critical Государственное бюджетное образовательное учреждение высшего профессионального образования "Дагестанская государственная медицинская академия министерства здравоохранения и социального развития"
Priority to RU2012144143/14A priority Critical patent/RU2534410C2/en
Publication of RU2012144143A publication Critical patent/RU2012144143A/en
Application granted granted Critical
Publication of RU2534410C2 publication Critical patent/RU2534410C2/en

Links

Abstract

Способ определения чувствительности химиопрепарата к злокачественной опухоли, заключающийся в исследовании чувствительности препарата, отличающийся тем, что материал, взятый из опухоли, обрабатывают химиопрепаратом в течение 1-2 ч, окрашивают по Романовскому-Гимзе и по наличию или отсутствию злокачественных клеток на предметном стекле определяют степень чувствительности.A method for determining the sensitivity of a chemotherapy drug to a malignant tumor, which consists in examining the sensitivity of a drug, characterized in that the material taken from the tumor is treated with a chemotherapy drug for 1-2 hours, stained according to Romanowsky-Giemsa and the degree or presence of malignant cells on a glass slide determines the degree of sensitivity.

Claims (1)

Способ определения чувствительности химиопрепарата к злокачественной опухоли, заключающийся в исследовании чувствительности препарата, отличающийся тем, что материал, взятый из опухоли, обрабатывают химиопрепаратом в течение 1-2 ч, окрашивают по Романовскому-Гимзе и по наличию или отсутствию злокачественных клеток на предметном стекле определяют степень чувствительности. A method for determining the sensitivity of a chemotherapy drug to a malignant tumor, which consists in examining the sensitivity of a drug, characterized in that the material taken from the tumor is treated with a chemotherapy drug for 1-2 hours, stained according to Romanowsky-Giemsa and the degree or presence of malignant cells on a glass slide determines the degree of sensitivity.
RU2012144143/14A 2012-10-16 2012-10-16 Method for determining tumour sensitivity to chemopreparation RU2534410C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2012144143/14A RU2534410C2 (en) 2012-10-16 2012-10-16 Method for determining tumour sensitivity to chemopreparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2012144143/14A RU2534410C2 (en) 2012-10-16 2012-10-16 Method for determining tumour sensitivity to chemopreparation

Publications (2)

Publication Number Publication Date
RU2012144143A true RU2012144143A (en) 2014-04-27
RU2534410C2 RU2534410C2 (en) 2014-11-27

Family

ID=50515127

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2012144143/14A RU2534410C2 (en) 2012-10-16 2012-10-16 Method for determining tumour sensitivity to chemopreparation

Country Status (1)

Country Link
RU (1) RU2534410C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2616532C1 (en) * 2015-12-28 2017-04-17 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации Method for assessment of tumour sensitivity to chemotherapy of patients with locally advanced breast cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2094802C1 (en) * 1994-08-16 1997-10-27 Воля Сергеевна Пашкова Method of determination of individual tumor chemiosensitivity in patients in vitro
UA31501U (en) * 2007-12-14 2008-04-10 Дочернее Предприятие «Военизированная Аварийно-Спасательная (Газоспасательная) Служба «Ликво» Нефтегазовой Промышленности» Device for placement of gate to mouth of gusher well
RU2413948C1 (en) * 2009-06-29 2011-03-10 Учреждение Российской академии медицинских наук Российский онкологический научный центр имени Н.Н. Блохина РАМН Method of immunofluorescent analysis of markers of multiple medication resistance in human solid tumours

Also Published As

Publication number Publication date
RU2534410C2 (en) 2014-11-27

Similar Documents

Publication Publication Date Title
TR201903526T4 (en) Conjugated compounds containing cysteine-engineered antibodies.
EA201692498A1 (en) METHODS FOR COLLECTING CULTURES OF MAMMALIAN CELLS
EA202091540A1 (en) ANTIBODIES TO LILRB2
EA201691866A1 (en) TUMOR LYMPHOCYTES PERMITTING FOR ADAPTIVE CELL THERAPY
EA201791167A1 (en) METHODS AND COMPOSITIONS FOR SWITCHING RADIOACTIVE ISOTOPOM FOR BIOLOGICAL PREPARATIONS
WO2016144728A3 (en) Anti-lilrb antibodies and their use in detecting and treating cancer
AR090973A1 (en) USEFUL ANTIBODIES FOR CANCER DIAGNOSIS
EA201991214A1 (en) ANTIBODIES AGAINST PD-1 AND THEIR COMPOSITION
EA201590671A1 (en) COMBINATION OF ANTIBODIES TO KIR AND ANTIBODIES TO PD-1 FOR THE TREATMENT OF MALIGNANT TUMOR
EA201692425A1 (en) MODIFIED BIOPOLYMERS AND METHODS OF THEIR PRODUCTION AND USE
EA201592005A1 (en) BICYCLIC HETEROCYCLES AS FGFR INHIBITORS
EA201790010A1 (en) GAMMA-DELTA T-CELLS AND THEIR APPLICATION
EA201590528A1 (en) ANTIBODIES TO MSAM AND METHODS OF THEIR APPLICATION
EP3683321A3 (en) Methods relating to circulating tumor cell clusters and the treatment of cancer
EP3274476A4 (en) Digital analysis of circulating tumor cells in blood samples
TR201909951T4 (en) A method for predicting the outcome of aflibercept treatment of a patient suspected of having cancer.
WO2018136919A3 (en) Methods relating to lung cancer
EA201691682A1 (en) METHODS FOR ANALYZING RARE CIRCULATING CELLS IN THE BLOOD
MX2016015163A (en) Mit biomarkers and methods using the same.
TW201614209A (en) Collection component and sample processing kit having the same
AR087363A1 (en) USE OF ANTIBODY I-3859 FOR THE DETECTION AND DIAGNOSIS OF CANCERES
EA201890739A1 (en) ANTI-S100A8 FOR THE TREATMENT OF LEUKEMIA
MA40636A (en) Methods of detecting prostate cancer
WO2015153997A3 (en) Notch3 antibodies and uses thereof
MX2016011748A (en) Humanized antibodies with increased stability.

Legal Events

Date Code Title Description
FZ9A Application not withdrawn (correction of the notice of withdrawal)

Effective date: 20140609

MM4A The patent is invalid due to non-payment of fees

Effective date: 20151017